OLYNTH HA 0.1% nasal spray 10ml., OLYNTH HA


Sale price £23.78 Regular price £30.00

Tax included. Shipping calculated at checkout.

OLYNTH HA 0.1% nasal spray Application:

Olynth HA is a nasal spray for acute runny nose, attacks of profuse nasal secretions (vasomotor rhinitis), allergic rhinitis (allergic rhinitis).

Facilitates the outflow of secretions in cases of paranasal sinusitis and catarrh of the tubal part of the middle ear in combination with colds.

With active ingredient - Xylometazoline. Xylometazoline is a sympathomimetic drug with a vasoconstrictive effect and thus reduces mucosal edema. Olint HA also contains hyaluronic acid, which moisturizes and protects the nasal mucosa.

Relieves nasal breathing by reducing mucosal swelling and improving the flow of secretions. The onset of action usually occurs within 5-10 minutes.

OLYNTH HA nasal spray Composition:

Active substance: xylometazoline.
Excipients: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, glycerol, sodium chloride, sorbitol, sodium hyaluronate, water for injections.

OLYNTH HA nasal spray Dosage:

Unless otherwise prescribed for adults and school-age children, apply 1 spray of Olint NA Dosing Spray in each nostril. The dosage depends on the individual sensitivity of the patient and the clinical effect.

The product is not a substitute for a varied diet.

OLYNTH HA nasal spray Contraindications:

This medicine should not be used in the following cases:

- hypersensitivity to one of the components of Olint 0.1%

- dry inflammation of the nasal mucosa (dry rhinitis) children under 6 years of age.

Due to the use of non-alconium chloride as a preservative, Olint 0.1% should not be used in case of known hypersensitivity to this substance.
This medicine should be used with careful consideration of the benefits and risks in patients:

- who have been treated with monoamine oxidase inhibitors (MAO inhibitors) or other medicines with potentially hypertensive effects

- in case of increased intraocular pressure, in particular narrow-angle glaucoma
with severe cardiovascular disease (eg ischemic heart disease, hypertension)

- with metabolic diseases (eg hyperthyroidism, diabetes).